LEXARIA BIOSCIENCE CORP. Net Assets
LEXARIA BIOSCIENCE CORP. (LEXX) had Net Assets of $9.79 million as of 2024-11-30, per its 10-Q filed 2025-01-10.
Financial Statements › Notes
us-gaap:AssetsNet · last filed 2025-01-10
- 2024-11-30: Net Assets $9.79M.
- 2024-08-31: Net Assets $8.87M.
- 2024-05-31: Net Assets $10.02M.
- 2024-02-29: Net Assets $6.35M.
| Period end | Net Assets | Net Assets as first filed |
|---|---|---|
| 2024-11-30 | $9.79M 10-Q · filed 2025-01-10 | |
| 2024-08-31 | $8.87M 10-K · filed 2024-11-26 | |
| 2024-05-31 | $10.02M 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $6.35M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $3.63M 10-Q · filed 2025-01-10 | $3.63M 10-Q · filed 2024-01-12 |
| 2023-08-31 | $3.08M 10-K · filed 2024-11-26 | |
| 2023-05-31 | $5.24M 10-Q · filed 2024-07-12 | |
| 2023-02-28 | $4.85M 10-Q · filed 2024-04-09 | |
| 2022-11-30 | $6.21M 10-Q · filed 2024-01-12 | |
| 2022-08-31 | $7.83M 10-K · filed 2023-11-20 | |
| 2021-08-31 | $13.27M 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |